A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor



Status:Completed
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - 65
Updated:11/30/-0001
Start Date:January 2013
End Date:November 2013
Contact:Medical Information
Email:medicalinfo@vrtx.com
Phone:617.341.6777

Use our guide to learn which trials are right for you!

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of VX-509 Using Magnetic Resonance Imaging and Arthroscopic Biopsies in Subjects With Active Rheumatoid Arthritis on Stable Disease-Modifying Antirheumatic Drugs


The current study is designed to evaluate the safety and efficacy, including MRI imaging,
across a range of VX-509 doses in subjects with active rheumatoid arthritis (RA) who have
had an inadequate response to disease-modifying antirheumatic drugs (DMARDs).


VX-509 is an oral, selective Janus kinase 3 (JAK3) inhibitor being developed by Vertex. In
autoimmune diseases, JAK3 is an essential component of the immune signaling cascade. This
cascade ultimately contributes to abnormal immune response that results in chronic
inflammation and, in the case of rheumatoid arthritis (RA), irreversible damage to cartilage
and bones. Selective inhibition of JAK3 offers a new disease modifying approach to the
treatment of RA, and a broad range of other autoimmune diseases.

Inclusion Criteria:

- Male and female subjects 18 to 65 years of age (inclusive)

- Diagnosis of RA

- Swollen joint count of ≥6 out of 66 joints and tender joint count of ≥6 out of 68
joints

- Seropositivity based on either a positive rheumatoid factor or anti cyclic
citrullinated peptide antibody at screening -OR- known erosive disease based on
previous X-ray report or erosions detected on screening hand and foot X-ray

- Baseline CRP level or Westergren erythrocyte sedimentation rate ≥1.2 × upper limit of
normal

- Receiving stable therapy with 1 of the following DMARDs: methotrexate, sulfasalazine,
leflunomide, anti-malarial drug, or penicillamine

- Palpable 2+ synovitis of the wrist or ≥2 MCPs in the MRI-designated hand

Exclusion Criteria:

- History or presence of a clinically significant medical disorder other than RA that,
in the opinion of the investigator and medical monitor, would pose a risk to subject
safety or interfere with the study evaluation, procedures, or completion.

- Inflammatory, rheumatological disorders other than RA, where arthritis may be a
prominent feature

- Planned surgery during the study

- History of alcohol or drug abuse, or excessive alcohol consumption

- History of tuberculosis (TB) infection of any kind (pulmonary or extrapulmonary,
active or latent), regardless of history of anti-TB treatment.

- Pregnant or nursing an infant or with a life partner who is pregnant, nursing, or
planning to become pregnant
We found this trial at
14
sites
Tustin, California
?
mi
from
Tustin, CA
Click here to add this to my saved trials
?
mi
from
Austin, TX
Click here to add this to my saved trials
Boca Raton, Florida
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Canton, Georgia
?
mi
from
Canton, GA
Click here to add this to my saved trials
Chapel Hill, North Carolina
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Charleston, South Carolina
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Elizabethtown, Kentucky
?
mi
from
Elizabethtown, KY
Click here to add this to my saved trials
Frederick, Maryland
?
mi
from
Frederick, MD
Click here to add this to my saved trials
Jackson, Tennessee
?
mi
from
Jackson, TN
Click here to add this to my saved trials
New Hyde Park, New York
?
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Omaha, Nebraska
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Pittsburgh, Pennsylvania
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Seattle, Washington
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Wichita, Kansas
?
mi
from
Wichita, KS
Click here to add this to my saved trials